| pubmed-article:1962827 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1962827 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:1962827 | lifeskim:mentions | umls-concept:C0017658 | lld:lifeskim |
| pubmed-article:1962827 | lifeskim:mentions | umls-concept:C0003241 | lld:lifeskim |
| pubmed-article:1962827 | lifeskim:mentions | umls-concept:C1261322 | lld:lifeskim |
| pubmed-article:1962827 | lifeskim:mentions | umls-concept:C1522492 | lld:lifeskim |
| pubmed-article:1962827 | pubmed:issue | 10 | lld:pubmed |
| pubmed-article:1962827 | pubmed:dateCreated | 1991-3-26 | lld:pubmed |
| pubmed-article:1962827 | pubmed:abstractText | Anti-neutrophil cytoplasmic antibodies (ANCA) have been found in patients with systemic vasculitis and crescentic glomerulonephritis. Recently two types of ANCA were identified, one is anti-myeloperoxidase antibodies (Anti-MPO Ab) stained perinuclear pattern of alcohol-fixed neutrophils by immunofluorescence test, and the other is autoantibodies with no reactivity with myeloperoxidase stained diffuse cytoplasmic pattern (C-ANCA). We investigated 59 patients with various glomerulonephritis with or without crescent to detect anti-MPO Ab and C-ANCA by an enzyme-linked immunosorbent assay. The results were as follows: 1) Anti-MPO Ab were detected only in patients with various glomerulonephritis with crescent. 2) Titers of anti-MPO Ab were high related to percentage of crescent in some cases of glomerulonephritis. 3) Titers of anti-MPO Ab were elevated at stage of cellular and fibro-cellular crescent. 4) C-ANCA were detected only in patients with Wegener's granulomatosis. These data suggested that anti-MPO Ab may play important roles in crescent formation and may be a marker of crescent formation in various glomerulonephritis. | lld:pubmed |
| pubmed-article:1962827 | pubmed:language | jpn | lld:pubmed |
| pubmed-article:1962827 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1962827 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1962827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1962827 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1962827 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1962827 | pubmed:month | Oct | lld:pubmed |
| pubmed-article:1962827 | pubmed:issn | 0385-2385 | lld:pubmed |
| pubmed-article:1962827 | pubmed:author | pubmed-author:NagasawaTT | lld:pubmed |
| pubmed-article:1962827 | pubmed:author | pubmed-author:TanakaUU | lld:pubmed |
| pubmed-article:1962827 | pubmed:author | pubmed-author:ArimuraYY | lld:pubmed |
| pubmed-article:1962827 | pubmed:author | pubmed-author:NohmiKK | lld:pubmed |
| pubmed-article:1962827 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1962827 | pubmed:volume | 32 | lld:pubmed |
| pubmed-article:1962827 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1962827 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1962827 | pubmed:pagination | 1087-93 | lld:pubmed |
| pubmed-article:1962827 | pubmed:dateRevised | 2011-8-1 | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:meshHeading | pubmed-meshheading:1962827-... | lld:pubmed |
| pubmed-article:1962827 | pubmed:year | 1990 | lld:pubmed |
| pubmed-article:1962827 | pubmed:articleTitle | [Clinical investigation of anti-myeloperoxidase antibodies in patients with glomerulonephritis with crescent formation]. | lld:pubmed |
| pubmed-article:1962827 | pubmed:affiliation | First Department of Internal Medicine, Kyorin University School of Medicine, Tokyo, Japan. | lld:pubmed |
| pubmed-article:1962827 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1962827 | pubmed:publicationType | English Abstract | lld:pubmed |
